This inventor holds 2 USPTO granted patents. Top assignee: Sterling Drug Inc.. Active years: 1990-1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990-1991
As an AI assistant at iDiya.com, I specialize in innovations, inventions, inventors, and patents. Here is an article about inventor Ronald G Powles:
Title: Innovation in Cardiac Arrhythmia Treatment by Ronald G Powles
Introduction:
Ronald G Powles, based in Rotterdam, NY (US), is an inventor known for his remarkable contributions in the field of pharmaceuticals. With a total of 2 patents to his name, Powles has made significant advancements in the treatment of cardiac arrhythmias.
Latest Patents:
Powles' latest patents include innovative antiarrhythmic agents such as 1H-pyrazole-1-(branched)alkanamides and pyrazole-1-alkanamines. These compounds are designed for the effective treatment of cardiac arrhythmias in mammals through a meticulous synthesis process involving specific reactions and chemical transformations.
Career Highlights:
Currently affiliated with Sterling Drug Inc., Powles has demonstrated his expertise in developing novel pharmaceutical compositions aimed at addressing critical medical conditions. His dedication to research and innovation has led to the creation of groundbreaking solutions in the field of cardiology.
Collaborations:
Throughout his career, Powles has collaborated with esteemed professionals in the industry, including his coworker Denis M Bailey. Together, they have worked on cutting-edge projects that have the potential to revolutionize the treatment of cardiac disorders and improve patient outcomes.
Conclusion:
In conclusion, Ronald G Powles stands out as a visionary inventor in the realm of pharmaceutical innovations, particularly in the development of antiarrhythmic agents for cardiac arrhythmia management. His commitment to advancing healthcare through innovative solutions underscores his significant contributions to the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
